20646-6 |
Homocystine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Homocystine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
20646-6 |
|
|
|
|
Both |
|
|
|
0 |
(Hcys)2 SerPl-sCnc |
|
|
|
Y |
|
(Hcys)2; Cardio; Cardiology; Chemistry; Heart Disease; Homocyst(e)ine; Homocystin; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20647-4 |
Hydroxyproline |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Hydroxyproline [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20647-4 |
|
|
|
|
Both |
|
|
|
0 |
OH-Proline SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Hydroxylproline; Hydroxyprol; Hydroxy-proline; Hydrxprol; Hydrxproln; Hydrxyprln; Hyp; Level; Ohpro; OH-Proline; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20648-2 |
Isoleucine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Isoleucine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20648-2 |
|
|
|
|
Observation |
|
|
|
0 |
Isoleucine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Ile; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20649-0 |
Leucine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Leucine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20649-0 |
|
|
|
|
Observation |
|
|
|
0 |
Leucine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Leu; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
2065-1 |
Chenodeoxycholate |
MCnc |
Ser |
Pt |
Qn |
|
|
DISCOURAGED |
Chenodeoxycholate [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
2065-1 |
|
|
|
|
Observation |
|
|
|
0 |
CDCAe Ser-mCnc |
|
|
|
Y |
|
CDCA; CDCAe; Chemistry; Chenodeoxycholic acid; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.73 |
1 |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
20650-8 |
Lysine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Lysine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20650-8 |
|
|
|
|
Observation |
|
|
|
0 |
Lysine SerPl-sCnc |
|
|
|
Y |
|
2,6-diaminohexanoic acid; Chemistry; Level; Lys; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20651-6 |
Methionine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Methionine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20651-6 |
|
|
|
|
Observation |
|
|
|
0 |
Methionine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Met; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20652-4 |
Ornithine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Ornithine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20652-4 |
|
|
|
|
Observation |
|
|
|
0 |
Ornithine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Orn; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20653-2 |
Phenylalanine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
DEPRECATED |
Deprecated Phenylalanine [Molecules/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
umol/L |
|
|
|
|
|
|
CHEM |
|
20653-2 |
|
|
|
|
|
|
|
|
0 |
Deprecated Phe SerPl-sCnc |
|
|
|
|
|
Chemistry; Level; Phe; Pl; Plasma; Plsm; Point in time; PPA; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.7 |
1.0m |
|
|
|
AssociatedObservations |
EXTERNAL_COPYRIGHT_LINK |
HL7_ATTACHMENT_STRUCTURE |
CONSUMER_NAME |
EXAMPLE_UCUM_UNITS |
STATUS_REASON |
STATUS_TEXT |
CHANGE_REASON_PUBLIC |
COMMON_TEST_RANK |
COMMON_ORDER_RANK |
20654-0 |
Phosphoserine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Phosphoserine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20654-0 |
|
|
|
|
Observation |
|
|
|
0 |
Phosphoserine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; PS; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20655-7 |
Proline |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Proline [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20655-7 |
|
|
|
|
Observation |
|
|
|
0 |
Proline SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; Pro; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20656-5 |
Serine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Serine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20656-5 |
|
|
|
|
Observation |
|
|
|
0 |
Serine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; Ser; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20657-3 |
Taurine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Taurine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20657-3 |
|
|
|
|
Observation |
|
|
|
0 |
Taurine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tau |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20658-1 |
Threonine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Threonine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20658-1 |
|
|
|
|
Observation |
|
|
|
0 |
Threonine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Thr |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20659-9 |
Tryptophan |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Tryptophan [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20659-9 |
|
|
|
|
Observation |
|
|
|
0 |
Tryptophan SerPl-sCnc |
|
|
|
Y |
|
c244; Chemistry; Level; L-tryptophan; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Trp |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
2066-9 |
Chenodeoxycholylglycine |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Chenodeoxycholylglycine [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
2066-9 |
|
|
|
|
Observation |
|
|
|
0 |
CDCG Ser-mCnc |
|
|
|
Y |
|
CDCG; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.34 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |
20660-7 |
Tyrosine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Tyrosine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20660-7 |
|
|
|
|
Both |
|
|
|
0 |
Tyrosine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Tyr; UniversalLabOrders |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20661-5 |
Valine |
SCnc |
Ser/Plas |
Pt |
Qn |
|
|
ACTIVE |
Valine [Moles/volume] in Serum or Plasma |
|
MIN |
DefinitionDescription |
|
|
mcmol/dL; mcmol/L; umol/L |
|
|
|
|
|
|
CHEM |
|
20661-5 |
|
|
|
|
Observation |
|
|
|
0 |
Valine SerPl-sCnc |
|
|
|
Y |
|
Chemistry; Level; Pl; Plasma; Plsm; Point in time; QNT; Quan; Quant; Quantitative; Random; SerP; SerPl; SerPlas; Serum; Serum or plasma; SR; Substance concentration; Val |
2.73 |
1.0m |
|
|
|
|
|
|
|
umol/L |
|
|
|
0 |
20662-3 |
Allergens tested for |
Prid |
Ser |
Pt |
Nom |
|
|
ACTIVE |
Allergens tested for in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
ALLERGY |
|
20662-3 |
|
|
|
|
Both |
|
|
|
0 |
Allergens Tested |
|
|
|
|
|
Allergen; Allergens; ALLERGY TESTING; Identity or presence; Nominal; Point in time; Random; Serum; SR |
2.73 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
20663-1 |
Tricyclic antidepressants |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Tricyclic antidepressants [Mass/volume] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20663-1 |
|
Screen |
|
|
Both |
|
|
|
0 |
Tricyclics Ur Scn-mCnc |
|
|
|
Y |
|
Antidepres; Antidepressant; DRUG/TOXICOLOGY; Drugs; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; TCA; Tricyclics; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
20664-9 |
Barbiturates |
MCnc |
Urine |
Pt |
Qn |
Screen |
|
ACTIVE |
Barbiturates [Mass/volume] in Urine by Screen method |
|
MIN |
DefinitionDescription |
|
|
ng/mL |
|
|
|
|
|
|
DRUG/TOX |
|
20664-9 |
|
Screen |
|
|
Both |
|
|
|
0 |
Barbiturates Ur Scn-mCnc |
|
|
|
Y |
|
Addiction; Barb; Barbiturate; Barbs; DRUG/TOXICOLOGY; Drugs; Drugs of abuse; Illicit; Level; Mass concentration; Point in time; PotentialForAbuse; QNT; Quan; Quant; Quantitative; Random; Scn; Scr; Scrn; UA; UR; Urn |
2.73 |
1.0m |
|
|
|
|
|
|
|
ng/mL |
|
|
|
0 |
20665-6 |
Echovirus 14 Ab.Neut |
Titr |
Ser |
Pt |
SemiQn |
Neut |
|
ACTIVE |
Echovirus 14 neutralizing antibody [Titer] in Serum by Neutralization test |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
MICRO |
|
20665-6 |
|
Neut |
|
|
Both |
|
|
|
0 |
ECV14 NAb Titr Ser Nt |
|
|
|
Y |
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Conventional virus neutralization test; cVNT; Dilution factor; Dilution Factor (Titer); Echo; Echo virus; Echovirus type 14; ECV; ECV14; EV; ID; Infectious Disease; InfectiousDisease; Microbiology; NAb; NEUTRALIZATION; Neutralization test; NT; Point in time; Random; Serum; Serum virus neutralization; SmQn; SR; SVN; Titer; Titered; Titre; Ttr; Virus neutralization test; VNT |
2.75 |
1.0m |
|
|
|
|
|
|
|
{titer} |
|
|
Release 2.72: COMPONENT: Updated "Ab" to "Ab.Neut" since this test is detecting neutralizing antibodies.; |
0 |
20666-4 |
Echovirus Ab |
Imp |
Ser |
Pt |
Nom |
|
|
ACTIVE |
Echovirus Ab [Interpretation] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
MICRO |
|
20666-4 |
|
|
|
|
Observation |
|
|
|
0 |
ECV Ab Ser-Imp |
|
|
|
|
|
ABS; Aby; Antby; Anti; Antibodies; Antibody; Autoantibodies; Autoantibody; Echo; Echo virus; ECV; EV; ID; Impression; Impression/interpretation of study; Impressions; Infectious Disease; InfectiousDisease; Interp; Interpretation; Microbiology; Nominal; Point in time; Random; Serum; SR |
2.26 |
1.0m |
|
|
|
|
|
|
|
|
|
|
|
0 |
20669-8 |
Cardiolipin Ab.IgA |
Titr |
Ser |
Pt |
SemiQn |
|
|
ACTIVE |
Cardiolipin IgA Ab [Titer] in Serum |
|
MAJ |
DefinitionDescription |
|
|
titer |
|
|
|
|
|
|
COAG |
|
20669-8 |
|
|
|
|
Both |
|
|
|
0 |
Cardiolipin IgA Titr Ser |
|
|
|
Y |
|
ABS; Aby; ACA; aCL; Antby; Anti; Antibodies; Antibody; Anticardiolipin; Autoantibodies; Autoantibody; Cardio; Cardiolip; Cardiolipn; Cardiolpn; CL; COAGULATION; Dilution factor; Dilution Factor (Titer); Hematology; Heme; Immune globulin A; Immunoglobulin A; Point in time; Random; Serum; SmQn; SR; Titer; Titered; Titre; Ttr |
2.75 |
1.0m |
|
|
|
|
|
|
|
{titer} |
|
|
|
0 |
2067-7 |
Chenodeoxycholylglycine.conjugated |
MCnc |
Ser |
Pt |
Qn |
|
|
ACTIVE |
Chenodeoxycholylglycine.conjugated [Mass/volume] in Serum |
|
MIN |
DefinitionDescription |
|
|
|
|
|
|
|
|
|
CHEM |
|
2067-7 |
|
|
|
|
Observation |
|
|
|
0 |
CDCG Conj Ser-mCnc |
|
|
|
Y |
|
CDCG; CDCG Conj; Chemistry; Level; Mass concentration; Point in time; QNT; Quan; Quant; Quantitative; Random; Serum; SR |
2.34 |
1 |
|
|
|
|
|
|
|
|
|
|
|
0 |